A purple and pink letter v on a white background.
June 14, 2023

Patient Education: Adding Value Through Informed Decision-Making

As a medical aesthetic practice, one of your key responsibilities is to empower your clients to make informed decisions about their aesthetic treatments. Patient education plays a vital role in fostering trust, enhancing satisfaction, and ensuring optimal treatment outcomes. In this blog, we will explore the importance of patient education and provide practical strategies to help you educate and engage your clients effectively.

The Value of Patient Education:

1. Building Trust: Educated patients feel confident in their decisions and trust the expertise of their providers. By providing comprehensive information, you establish a foundation of trust and credibility, fostering a positive patient-practitioner relationship.

2. Managing Expectations: Educating patients about the benefits, limitations, and potential outcomes of treatments helps set realistic expectations. When patients have a clear understanding of what to expect before, during, and after the treatment, they are more likely to be satisfied with their results.

3. Safety and Informed Consent: Patient education ensures that clients are aware of the potential risks, side effects, and aftercare instructions associated with aesthetic treatments. Informed consent plays a critical role in ensuring patient safety and ethical practice.

Effective Strategies for Patient Education:

1. Consultation Process: The initial consultation is an ideal opportunity to educate patients. Take the time to understand their goals, explain treatment options, and discuss expected outcomes. Use visual aids, brochures, and educational videos to enhance understanding.

2. Clear Communication: Use plain language and avoid technical jargon to ensure patients can grasp the information easily. Break down complex concepts into digestible segments and encourage patients to ask questions for clarification.

3. Visual Demonstrations: Incorporate visual demonstrations to help patients visualize the treatment process and outcomes. Before-and-after photos, videos, or 3D simulations can be powerful tools to showcase the potential results.

4. Written Materials: Provide written materials such as treatment guides, brochures, FAQs, and post-treatment instructions. These resources serve as valuable references for patients to review at their own pace.

5. Online Resources: Leverage your digital presence, especially your website and social media platforms to offer educational content. Create blogs, social media posts, articles, and videos that discuss different treatments, address common concerns, and provide insights into the latest aesthetic trends.

6. Testimonials and Case Studies : Share success stories from satisfied patients who have undergone treatments at your practice. Real-life experiences can inspire and educate potential clients, giving them a glimpse of the transformative power of aesthetic treatments.

Empowering Informed Decision-Making:

1. Individualized Treatment Plans: Tailor treatment plans to each patient's unique needs and goals. Explain the rationale behind the chosen treatments, considering factors such as skin type, concerns, and lifestyle.

2. Benefits and Alternatives: Provide a thorough explanation of the benefits of the recommended treatment, as well as any viable alternatives. Present the pros and cons of each option, allowing patients to make an educated choice based on their preferences.

3. Follow-Up and Support: Encourage open communication and establish a follow-up system to address any post-treatment concerns or questions. This ongoing support reinforces patient trust and enhances the overall experience.

Patient education is a cornerstone of successful aesthetic practices. By providing comprehensive information, clear communication, and engaging resources, you empower your clients to make informed decisions about their aesthetic treatments. Remember, an educated patient is a satisfied patient. Invest in patient education to foster trust, manage expectations, and deliver exceptional care. Together, let's create an environment where clients feel empowered and confident in their aesthetic journey.

September 9, 2026
TORONTO, September 9 th , 2026 (GLOBE NEWSWIRE) – Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced the appointment of Brad Oliver as Chief Executive Officer, effective as of September 7, 2026. He succeeds Rajiv De Silva, who will assume the role of Special Advisor to support a seamless leadership transition. The Board believes that Brad’s commercial leadership experience, strategic vision, and industry expertise position the Company well for its next phase of growth and value creation. Brad brings more than 20 years of leadership experience in the aesthetic industry, most recently as President & General Manager – Americas at Lumenis, and has a proven track record of driving growth globally, operational excellence, and innovation. "I am honored to be appointed Chief Executive Officer of Venus Concept and grateful for the confidence the Board has placed in me,” said Mr. Oliver. “The Company has established a strong foundation under Rajiv's leadership, and I look forward to working closely with him during the transition. Together with our employees, customers, and partners, we will remain focused on disciplined commercial execution, product innovation, profitable growth, and creating long-term value for our customers, employees, and shareholders.” “It has been a pleasure to lead Venus through a transformational time in the organization’s journey,” said Mr. De Silva. “I am grateful for the opportunity to work together with the leadership team, the Board and our partners to grow the business. We have transformed the commercial, operational and financial capabilities of the organization and built a strong foundation for the future. I remain highly confident in the Company’s strategy, pipeline and long-term growth opportunities. I look forward to supporting a smooth transition and watching Venus continue its transformation under Brad’s new leadership.” The Board expresses its gratitude to Rajiv for his leadership and ongoing commitment to the Company. As Special Advisor, Rajiv will work closely with Brad during the transition period to ensure continuity across strategic, operational, and customer-facing initiatives. “On behalf of the Board, I would like to thank Rajiv for his leadership and contributions to the Company and for his support during this transition to ensure a seamless handoff of leadership responsibilities,” said Avinash Amin, M.D., Managing Partner of Madryn Asset Management and Chairman of the Board. “The Board looks forward to Brad’s new leadership of the organization and is confident that his expertise will accelerate commercial efforts globally and the execution of its strategic priorities as the company progresses towards continuing to establish a leadership position in the Medical Device Aesthetics industry.” The leadership transition is not expected to impact the Company’s strategic priorities, customer relationships, employee commitments, or ongoing business operations. Venus Concept remains focused on delivering innovative solutions to its customers, expanding market opportunities, and driving sustainable long-term growth. About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft ® and the ARTAS iX ® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. View Full Article Investor Relations Contact : Damian Yeung, CPA investorrelations@venus.ai
By Yoni Nowmalki July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.